HomeMarketsCurrencies & CryptoAmgen (AMGN) Sales Higher After Obesity Drug Results
00:00
00:00
03:49
Amgen (AMGN) Sales Higher After Obesity Drug Results

Amgen (AMGN) Sales Higher After Obesity Drug Results

Amgen (AMGN) sales are higher after early results from a study of an obesity drug. Renita Young discusses this as the Amgen CEO is “very encouraged” by the results of the obesity drug study. Tune in to find out more about the stock market today.

Morning Trade Live

03 May 2024

SHARE

ON AIR
education
10:30 pm
Your First Trade
replay
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:00 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
education
1:00 pm
Inside the Mind of a Trader
REPLAY
education
1:30 pm
Inside the Mind of a Trader
REPLAY
education
2:00 pm
Inside the Mind of a Trader
REPLAY
2:30 pm
Market Overtime
REPLAY
3:00 pm
Gamma On
REPLAY
3:30 pm
Gamma On
REPLAY
4:00 pm
Gamma On
REPLAY
4:30 pm
Gamma On
REPLAY
5:30 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
6:30 pm
Gamma On
REPLAY
7:00 pm
Gamma On
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Gamma On
REPLAY
education
10:00 pm
Your First Trade
REPLAY
ON AIR
education
10:30 pm
Your First Trade
REPLAY
education
11:00 pm
Your First Trade
REPLAY
education
11:30 pm
Your First Trade
REPLAY
education
12:00 am
Your First Trade
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Gamma On
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY

Get the Market Minute

Daily insights for every investor